← Eichor
Study identifier: NCT04488601 Synced from ClinicalTrials.gov · July 28, 2026
● Completed

Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study

Condition: Aging  ·  Sponsor: AgelessRx

PhasePhase 2
Planned participants129
Who can joinAll sexes, 50 Years to 85 Years
Healthy volunteersYes

About this study

This is a randomized, placebo-controlled trial into the safety and efficacy in reducing clinical measures of aging in an older adult population.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (1)

AgelessRxChicago, Illinois, United States

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04488601